Fulgent Genetics (FLGT) Cash from Discontinued Operations (2015 - 2016)
Fulgent Genetics (FLGT) posted Cash from Discontinued Operations of 14000.0 for Q2 2016, up 17.65% sequentially from 17000.0 in Q1 2016.
Fulgent Genetics (FLGT) Cash from Discontinued Operations (2015 - 2016) Analysis & Trends
Fulgent Genetics has reported Cash from Discontinued Operations for 2 years, with the latest figure at 14000.0 in Q2 2016.
- Quarterly Cash from Discontinued Operations changed N/A year-over-year to 14000.0 in Q2 2016, while the trailing twelve-month figure through Dec 2016 was 31000.0 (changed N/A YoY) and the FY2016 annual result came in at 31000.0, up 98.96% from the prior year.
- Cash from Discontinued Operations climbed to 14000.0 in Q2 2016 per FLGT's latest filing, from 17000.0 in the prior quarter.
- Over five years, Cash from Discontinued Operations peaked at 14000.0 in Q2 2016 and troughed at 916000.0 in Q4 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discont. Ops (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | - |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | - |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | - |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | - |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | - |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | - |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | - |
| 10 | Fulgent Genetics | 557.44 Mn | 300.41 Mn | 25.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2016 | -14,000.00 |
| Jun 30, 2016 | -14,000.00 |
| Mar 31, 2016 | -17,000.00 |
| Mar 31, 2016 | -17,000.00 |
| Dec 31, 2015 | -916,000.00 |
| Dec 31, 2015 | -916,000.00 |